Can-Fite BioPharma (CANF) director holds 16,000 unvested options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Can-Fite BioPharma Ltd. director Tamir Ilan reported his initial beneficial ownership, consisting of options to purchase 16,000 Ordinary Shares. These options have an exercise price of $2.25 per share and expire on April 25, 2036.
None of the options are currently vested. All 16,000 options vest in sixteen equal quarterly installments from April 25, 2026 through January 25, 2030, subject to his continued service with the company. The options were granted under Can-Fite’s share option plans and are held through a trustee to qualify for tax benefits under Section 102 of the Israeli Tax Ordinance. The exercise price was originally set at NIS 6.767 and is presented in U.S. dollars using a Bank of Israel exchange rate of NIS 3.003 = USD 1.00 as of April 20, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Tamir Ilan
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options to Purchase Ordinary Shares — 16,000 shares (Direct, null)
Footnotes (1)
- To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2003 Share Option Plan, 2013 Share Option Plan and 2023 Share Option Plan must be registered in the name of a trustee. Of the options reported herein, none are vested, and all the 16,000 options vest in sixteen equal quarterly installments beginning 04/25/2026 and ending 01/25/2030 subject to the Reporting Person's continued service to the Issuer as of such vesting date. The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 6.767, is presented in the table in U.S. Dollars ("USD") based on the exchange rate reported by the Bank of Israel on April 20, 2026, which was NIS 3.003 = USD 1.00.
Key Figures
Options granted: 16,000 options
Exercise price: $2.25 per share
Original NIS exercise price: NIS 6.767
+4 more
7 metrics
Options granted
16,000 options
Options to Purchase Ordinary Shares reported as beneficially owned
Exercise price
$2.25 per share
Exercise price for options to purchase Can-Fite Ordinary Shares
Original NIS exercise price
NIS 6.767
Original exercise price denominated in New Israeli Shekels
FX rate used
NIS 3.003 = USD 1.00
Bank of Israel exchange rate as of April 20, 2026
Vesting period start
April 25, 2026
First quarterly vesting date for the 16,000 options
Vesting period end
January 25, 2030
Final quarterly vesting date for the 16,000 options
Option expiration
April 25, 2036
Expiration date of the reported options
Key Terms
Section 102 of the Israeli Tax Ordinance, 2003 Share Option Plan, exercise price, vesting, +1 more
5 terms
Section 102 of the Israeli Tax Ordinance financial
"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee..."
exercise price financial
"The exercise price of this option, originally denominated in New Israeli Shekels..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"none are vested, and all the 16,000 options vest in sixteen equal quarterly installments..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
trustee financial
"securities issued to an employee... must be registered in the name of a trustee."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What did Can-Fite BioPharma (CANF) director Tamir Ilan report on this Form 3?
Director Tamir Ilan reported holding options to purchase 16,000 Can-Fite Ordinary Shares. These options are compensation-related, not an open-market trade, and reflect his initial beneficial ownership disclosure as a director of the company.
What is the exercise price of Tamir Ilan’s Can-Fite (CANF) options?
The options reported have an exercise price of $2.25 per share. This U.S. dollar figure reflects an original New Israeli Shekel price of NIS 6.767, converted using a Bank of Israel exchange rate of NIS 3.003 per USD.
When do Tamir Ilan’s Can-Fite (CANF) options vest and expire?
All 16,000 options vest in sixteen equal quarterly installments from April 25, 2026 through January 25, 2030. The options expire on April 25, 2036, giving him a multi-year window to exercise vested awards.
Are any of Tamir Ilan’s Can-Fite (CANF) options vested yet?
None of the options reported are vested at this time. Vesting begins on April 25, 2026 and continues quarterly until January 25, 2030, and requires that Tamir Ilan remain in service with Can-Fite through each vesting date.
Why are Tamir Ilan’s Can-Fite (CANF) options held by a trustee?
The options are registered in the name of a trustee to qualify for tax benefits under Section 102 of the Israeli Tax Ordinance. Israeli equity compensation often uses trustees so employees can benefit from favorable tax treatment on their awards.